PNV 1.24% $2.38 polynovo limited

The Clinicians Speak, page-137

  1. 11 Posts.
    lightbulb Created with Sketch. 34

    Here is our groups most recent publication.

    Wu SS, Wells M, Ascha M, Gatherwright J, Chepla K. Performance of biodegradable temporizing matrix vs collagen-chondroitin silicone bilayer dermal regeneration substitutes in soft tissue wound healing: a retrospective analysis. Wounds. 2022 Apr;34(4):106-115. PMID: 35452408.

    97 patients. Comparison of Integra to BTM. Some methodological issues because Integra primarily in burn patients and BTM in trauma. However, would say that BTM used for more "complex" wounds - Poorly vascularized wound bed, etc. BTM had higher "template infection" but SIGNIFICANTLY lower skin graft failure and need for secondary surgery (primary healing over the temple). People may latch on to template infection thing but that was just the term we used to describe a fluid collection under a portion of the template. Key point here is that this did not result in loss of the template (as you would see with a biologic). Despite this there was no difference in definitive wound closure between the two. And BTM is way cheaper as a product. We also did not calculate indirect savings as a result of decreased need for revision / secondary surgery.

    Keep holding...

 
watchlist Created with Sketch. Add PNV (ASX) to my watchlist
(20min delay)
Last
$2.38
Change
-0.030(1.24%)
Mkt cap ! $1.642B
Open High Low Value Volume
$2.42 $2.44 $2.36 $4.288M 1.798M

Buyers (Bids)

No. Vol. Price($)
4 28177 $2.37
 

Sellers (Offers)

Price($) Vol. No.
$2.38 26895 1
View Market Depth
Last trade - 16.10pm 21/06/2024 (20 minute delay) ?
PNV (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.